Johnson Financial Group Inc (Wisconsin)’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10	Closed	-$1.38K	–	1002
2024 Q2	$1.38K	Buy	+10	New	+$1.38K	﹤0.01%	698
2022 Q1	–	Sell	-144	Closed	-$12K	–	766
2021 Q4	$12K	Buy	+144	New	+$12K	﹤0.01%	607